The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells presents a paramount challenge with the biopharmaceutical industry. Various strategies are employed to antibody titer, including process parameter optimization, genetic engineering, and the use of perfusion processes. Fine-tuning media composition plays a cru